BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Staging
10 results:

  • 1. Impact of Pleural Lavage Cytology Positivity on Early Recurrence After Surgery for Non-Small Cell lung cancer.
    Recuero Díaz JL; Gatius Caldero S; Rosado Rodríguez J; Caamaño Villaverde V; Gómez de Antonio D; Tejerina E; Sánchez Moreno L; Martino González M; Moldes Rodríguez M; Abdulkader Nallib I; Ramírez Gil E; Amat Villegas I; Genovés Crespo M; García Ángel R; Sampedro Salinas C; Figueroa Almánzar S; Compañ Quilis A; Saumench Perramon R; González Pont G; Royo Crespo Í; Gambó Grasa P; García Fernández JL; Jiménez Heffernan JA; Cerón Navarro J; Prieto Rodríguez M; Porcel JM
    Arch Bronconeumol; 2024 Mar; 60(3):133-142. PubMed ID: 38238188
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study.
    Wu LL; Li CW; Lin WK; Qiu LH; Xie D
    BMC Cancer; 2021 Sep; 21(1):1009. PubMed ID: 34496775
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidence of and Risk Factors for Tuberculosis among cancer Patients in Endemic Area: A Regional Cohort Study.
    Nanthanangkul S; Promthet S; Suwanrungruang K; Santong C; Vatanasapt P
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2715-2721. PubMed ID: 32986373
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?
    Yoo GS; Oh D; Pyo H; Ahn YC; Noh JM; Park HC; Lim DH
    J Radiat Res; 2019 Mar; 60(2):234-241. PubMed ID: 30544255
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Convolutional Neural Networks Promising in lung cancer T-Parameter Assessment on Baseline FDG-PET/CT.
    Kirienko M; Sollini M; Silvestri G; Mognetti S; Voulaz E; Antunovic L; Rossi A; Antiga L; Chiti A
    Contrast Media Mol Imaging; 2018; 2018():1382309. PubMed ID: 30510492
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Quantitative Clinical staging for Patients With Malignant Pleural Mesothelioma.
    Gill RR; Yeap BY; Bueno R; Richards WG
    J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
    Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1345-51. PubMed ID: 19910140
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Promoter hypermethylation for molecular nodal staging in non-small cell lung cancer.
    Safar AM; Spencer H; Su X; Cooney CA; Shwaiki A; Fan CY
    Arch Pathol Lab Med; 2007 Jun; 131(6):936-41. PubMed ID: 17550322
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period.
    Ge MJ; Shi D; Wu QC; Wang M; Li LB
    J Cancer Res Clin Oncol; 2006 Apr; 132(4):248-56. PubMed ID: 16320073
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The value of bone marrow examination in small cell carcinoma of the lung.
    Hørlyck A; Henriques U; Jakobsen A
    Acta Oncol; 1994; 33(8):909-11. PubMed ID: 7818924
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.